Recurrence of Adrenal Cortical Carcinoma Following Resection: Surgery Alone Can Achieve Results Equal to Surgery Plus Mitotane

[1]  T. Fojo,et al.  Adjuvant mitotane for adrenocortical cancer--a recurring controversy. , 2008, The Journal of clinical endocrinology and metabolism.

[2]  R. Vassilopoulou-sellin,et al.  Systemic chemotherapy for adrenocortical carcinoma: comparative responses to conventional first-line therapies , 2008, Anti-cancer drugs.

[3]  Jeffrey E. Lee,et al.  Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma. , 2007, Surgery.

[4]  O. Nativ,et al.  Adjuvant mitotane in adrenocortical carcinoma. , 2007, The New England journal of medicine.

[5]  H. Dralle,et al.  Adjuvant mitotane in adrenocortical carcinoma. , 2007, The New England journal of medicine.

[6]  Thomas H. Lee.  Eulogy for a quality measure. , 2007, The New England journal of medicine.

[7]  J. Bertherat,et al.  Adjuvant mitotane in adrenocortical carcinoma. , 2007, The New England journal of medicine.

[8]  M. Papotti,et al.  Adjuvant mitotane treatment for adrenocortical carcinoma. , 2007, The New England journal of medicine.

[9]  Martin Fassnacht,et al.  Adrenocortical Carcinoma: Clinical Update , 2006 .

[10]  Jeffrey E. Lee,et al.  Laparoscopic resection of adrenal cortical carcinoma: a cautionary note. , 2005, Surgery.

[11]  T. Giordano,et al.  Management of patients with adrenal cancer: recommendations of an international consensus conference. , 2005, Endocrine-related cancer.

[12]  W. Young,et al.  Aldosterone-secreting adrenocortical carcinomas are associated with unique operative risks and outcomes. , 2002, Surgery.

[13]  Y. Chapuis,et al.  Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group , 2001, World Journal of Surgery.

[14]  A. Kasperlik-Załuska.  Clinical results of the use of mitotane for adrenocortical carcinoma. , 2000, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[15]  M. Brennan,et al.  Long-Term Survival After Complete Resection and Repeat Resection in Patients With Adrenocortical Carcinoma , 1999, Annals of Surgical Oncology.

[16]  V. Budach,et al.  [Adrenal cortical carcinoma]. , 1999, Zhonghua wai ke za zhi [Chinese journal of surgery].

[17]  A. Makowska,et al.  Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer: Two years later , 1996, Cancer.

[18]  D. Berger,et al.  Surgical management, DNA content, and patient survival in adrenal cortical carcinoma. , 1995, Surgery.

[19]  G. Fleuren,et al.  Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. , 1994, British Journal of Cancer.

[20]  Y. Chapuis,et al.  Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgery. , 1992, Surgery.

[21]  J. Montie,et al.  The Cleveland Clinic experience with adrenal cortical carcinoma. , 1989, The Journal of urology.